Background: Circle of Willis (COW) variants might influence arterial caliber in the brain. We hypothesized that these variants would be associated with the prevalence of intracranial dolichoectasia (DE). Methods: We examined COW variants and DE in a sample of stroke-free participants (n = 436) undergoing magnetic resonance angiography (MRA) as part of a population-based study. Large intracranial arterial diameters were obtained when available; if not, the artery was defined as hypoplastic or absent according to its visibility on MRA. Subscores for the anterior and the posterior circulations were created. DE was defined as arterial diameters ≥2 SD above the population mean for that artery, adjusting for intracranial volume. Generalized linear models with a Poisson distribution were used to evaluate predictors of both absent and hypoplastic vessels, and logistic regression was used to assess the odds ratio (OR) and 95% confidence interval (95% CI) of DE depending on COW variants. Results: Only 44% of the sample had all 14 arteries present, 32% lacked 1 artery, 18% lacked 2 and 6% lacked 3 or more. DE of at least 1 artery was not associated with the total number of hypoplastic or absent arteries, but DE in a posterior circulation artery was weakly associated with the number of absent arteries in the posterior circulation (β coefficient = 0.36, p = 0.06). DE of at least 1 artery was more frequent in those with 1 or more absent arteries (OR 1.27, 95% CI 1.03-1.57). Posterior circulation DE was more frequent in participants with at least 1 or more absent arteries at any location (OR 1.35, 95% CI 1.02-1.78). Participants with an incomplete posterior COW were more likely to have DE in the anterior circulation (OR 1.52, 95% CI 1.01-2.33). Having an absent left anterior cerebral artery (ACA) A1 segment was associated with right ACA DE (OR 34.1, 95% CI 3.16-368.2); an absent right ACA was associated with left ACA DE (OR 14.1, 95% CI 1.69-118.28). Absence of 1 (OR 1.9, 95% CI 1.1-3.4) or 2 (OR 3.0, 95% CI 1.4-6.6) of the 2 arteries connecting the anterior to the posterior circulation was associated with basilar artery DE. Conclusion: The COW is a pleomorphic structure that allows collateral flow to compensate for an insufficient or absent arterial component at the base of the skull. By presumed flow diversion, arteries might undergo outward remodeling. Whether this compensatory arterial dilatation is beneficial or not remains unknown.

Keywords:
Dolichoectasia, Circle of Willis anatomy, Arterial diameters
1.
Smoker WR, Corbett JJ, Gentry LR, Keyes WD, Price MJ, McKusker S: High-resolution computed tomography of the basilar artery. 2. Vertebrobasilar dolichoectasia: clinical-pathologic correlation and review. AJNR Am J Neuroradiol 1986;7:61-72.
2.
Yu YL, Moseley IF, Pullicino P, McDonald WI: The clinical picture of ectasia of the intracerebral arteries. J Neurol Neurosurg Psychiatry 1982;45:29-36.
3.
Passero SG, Calchetti B, Bartalini S: Intracranial bleeding in patients with vertebrobasilar dolichoectasia. Stroke 2005;36:1421-1425.
4.
Flemming KD, Wiebers DO, Brown RD Jr, Link MJ, Huston J 3rd, McClelland RL, Christianson TJ: The natural history of radiographically defined vertebrobasilar nonsaccular intracranial aneurysms. Cerebrovasc Dis 2005;20:270-279.
5.
Ubogu EE, Chase CM, Verrees MA, Metzger AK, Zaidat OO: Cervicomedullary junction compression caused by vertebral artery dolichoectasia and requiring surgical treatment. Case report. J Neurosurg 2002;96:140-143.
6.
Papapetropoulos S, Argyriou AA, Guevara A, Sengun C, Mitsi G, Singer C: Hemifacial spasm and pontine compression caused by a giant vertebrobasilar dolichoectasia. Cerebrovasc Dis 2009;27:413-414.
7.
Mangrum WI, Huston J 3rd, Link MJ, Wiebers DO, McClelland RL, Christianson TJ, Flemming KD: Enlarging vertebrobasilar nonsaccular intracranial aneurysms: frequency, predictors, and clinical outcome of growth. J Neurosurg 2005;102:72-79.
8.
Kwon HM, Kim JH, Lim JS, Park JH, Lee SH, Lee YS: Basilar artery dolichoectasia is associated with paramedian pontine infarction. Cerebrovasc Dis 2009;27:114-118.
9.
Passero SG, Rossi S: Natural history of vertebrobasilar dolichoectasia. Neurology 2008;70:66-72.
10.
Wolfe T, Ubogu EE, Fernandes-Filho JA, Zaidat OO: Predictors of clinical outcome and mortality in vertebrobasilar dolichoectasia diagnosed by magnetic resonance angiography. J Stroke Cerebrovasc Dis 2008;17:388-393.
11.
Lehoux S, Castier Y, Tedgui A: Molecular mechanisms of the vascular responses to haemodynamic forces. J Intern Med 2006;259:381-392.
12.
Nguyen KT, Clark CD, Chancellor TJ, Papavassiliou DV: Carotid geometry effects on blood flow and on risk for vascular disease. J Biomech 2008;41:11-19.
13.
Nixon AM, Gunel M, Sumpio BE: The critical role of hemodynamics in the development of cerebral vascular disease. J Neurosurg 2010;112:1240-1253.
14.
Meng H, Wang Z, Hoi Y, Gao L, Metaxa E, Swartz DD, Kolega J: Complex hemodynamics at the apex of an arterial bifurcation induces vascular remodeling resembling cerebral aneurysm initiation. Stroke 2007;38:1924-1931.
15.
Nakatomi H, Segawa H, Kurata A, Shiokawa Y, Nagata K, Kamiyama H, Ueki K, Kirino T: Clinicopathological study of intracranial fusiform and dolichoectatic aneurysms: insight on the mechanism of growth. Stroke 2000;31:896-900.
16.
Boden-Albala B, Cammack S, Chong J, Wang C, Wright C, Rundek T, Elkind MS, Paik MC, Sacco RL: Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care 2008;31:1132-1137.
17.
Jiang H, Alperin N: A new automatic skeletonization algorithm for 3D vascular volumes. Conf Proc IEEE Eng Med Biol Soc 2004;2:1565-1568.
18.
Gutierrez J, Bagci A, Gardener H, Rundek T, Ekind MSV, Alperin N, Sacco RL, Wright CB: Dolichoectasia diagnostic methods in a multi-ethnic, stroke-free cohort: results from the Northern Manhattan Study. J Neuroimaging 2013, E-pub ahead of print.
19.
Willis T, Pordage S, Dring T, Harper C, Leigh J: Dr. Willis's Practice of Physick: Being the Whole Works of That Renowned and Famous Physician: Containing These Eleven Several Treatises, viz. London, Printed for T Dring, C Harper, and J Leigh, 1684.
20.
van der Zwan A, Hillen B, Tulleken CA, Dujovny M: A quantitative investigation of the variability of the major cerebral arterial territories. Stroke 1993;24:1951-1959.
21.
Hillen B: The variability of the circle of Willis: univariate and bivariate analysis. Acta Morphol Neerl Scand 1986;24:87-101.
22.
Derdeyn CP, Videen TO, Yundt KD, Fritsch SM, Carpenter DA, Grubb RL, Powers WJ: Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain 2002;125:595-607.
23.
Liebeskind DS, Sanossian N: How well do blood flow imaging and collaterals on angiography predict brain at risk? Neurology 2012;79:S105-S109.
24.
Padget D: The circle of Willis: its embryology and anatomy; in Dandy WE (ed): Intracranial Arterial Aneurysms. Ithaca, Comstock Publishing Company, Cornell University, 1944, pp 67-90.
25.
Alpers BJ, Berry RG, Paddison RM: Anatomical studies of the circle of Willis in normal brain. AMA Arch Neurol Psychiatry 1959;81:409-418.
26.
Riggs HE, Rupp C: Variation in form of circle of Willis. The relation of the variations to collateral circulation: anatomic analysis. Arch Neurol 1963;8:8-14.
27.
Leblanc GG, Golanov E, Awad IA, Young WL: Biology of vascular malformations of the brain. Stroke 2009;40:e694-e702.
28.
Risau W: Mechanisms of angiogenesis. Nature 1997;386:671-674.
29.
Van Overbeeke JJ, Hillen B, Tulleken CA: A comparative study of the circle of Willis in fetal and adult life. The configuration of the posterior bifurcation of the posterior communicating artery. J Anat 1991;176:45-54.
30.
Burger IM, Siclari F, Gregg L, Gailloud P: Bilateral segmental agenesis of the vertebrobasilar junction: developmental and angiographic anatomy. AJNR Am J Neuroradiol 2007;28:2017-2022.
31.
Kier LE: Section I. Fetal cerebral arteries: a phylogenetic and ontogenic study; in Newton TH, Potts DG (eds): Radiology of the Skull and Brain. Saint Louis, Mosby, 1971, pp 1089-1130.
32.
Krabbe-Hartkamp MJ, van der Grond J, de Leeuw FE, de Groot JC, Algra A, Hillen B, Breteler MM, Mali WP: Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology 1998;207:103-111.
33.
El-Barhoun EN, Gledhill SR, Pitman AG: Circle of Willis artery diameters on MR angiography: an Australian reference database. J Med Imaging Radiat Oncol 2009;53:248-260.
34.
Riles TS, Eidelman EM, Litt AW, Pinto RS, Oldford F, Schwartzenberg GW: Comparison of magnetic resonance angiography, conventional angiography, and duplex scanning. Stroke 1992;23:341-346.
35.
Patrux B, Laissy JP, Jouini S, Kawiecki W, Coty P, Thiebot J: Magnetic resonance angiography (MRA) of the circle of Willis: a prospective comparison with conventional angiography in 54 subjects. Neuroradiology 1994;36:193-197.
36.
Ford MD, Alperin N, Lee SH, Holdsworth DW, Steinman DA: Characterization of volumetric flow rate waveforms in the normal internal carotid and vertebral arteries. Physiol Meas 2005;26:477-488.
37.
Cebral JR, Castro MA, Putman CM, Alperin N: Flow-area relationship in internal carotid and vertebral arteries. Physiol Meas 2008;29:585-594.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.